Search - tctmd.com

Displaying 41 - 60 of 187

Sort: Relevancy | Date

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

News Conference News ESC 2021

IAMI: Influenza Vaccine Beneficial for Post-MI Patients

Michael O'Riordan

August 30, 2021

FFR During Angiogram Not Beneficial in Chest Pain Patients: RIPCORD 2

News Conference News ESC 2021

FFR During Angiogram Not Beneficial in Chest Pain Patients: RIPCORD 2

Michael O'Riordan

August 29, 2021

TOMAHAWK: Swift Angiography No Benefit in OHCA Without STEMI

News Conference News ESC 2021

TOMAHAWK: Swift Angiography No Benefit in OHCA Without STEMI

August 29, 2021

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

News Conference News ESC 2021

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

August 28, 2021

Colchicine in STEMI Fails to Reduce Infarct Size: COVERT-MI

News Daily News ESC 2021

Colchicine in STEMI Fails to Reduce Infarct Size: COVERT-MI

August 26, 2021

Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5

News Conference News ESC 2021

Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5

August 24, 2021

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

News Conference News ESC 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

September 03, 2020

In Long-term, Real-world Data CABG Bests PCI for Diabetic Patients With MVD

News Conference News ESC 2020

In Long-term, Real-world Data, CABG Bests PCI for Diabetic Patients With MVD

Yael L. Maxwell

September 01, 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease

News Conference News ESC 2020

LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease

August 31, 2020

Trimetazidine Safe but Not Protective Long-term After PCI

News Conference News ESC 2020

Trimetazidine Safe but Not Protective Long-term After PCI

August 30, 2020

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

News Conference News ESC 2019

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

September 10, 2019

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

News Conference News ESC 2019

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

September 09, 2019

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

News Conference News ESC 2019

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

Michael O'Riordan

September 05, 2019

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)31997-X/fulltext

News Conference News ESC 2019

Ten-Year SYNTAXES Results Fix Roles for CABG, PCI in Complex CAD

September 05, 2019

Stopped Early, DAPA Offers Insight on ICD Timing After STEMI

News Conference News ESC 2019

Stopped Early, DAPA Offers Insight on ICD Timing After STEMI

September 04, 2019

Transfer for Primary PCI Still Better Than Fibrinolysis After 16 Years: DANAMI-2

News Conference News ESC 2019

Transfer for Primary PCI Still Better Than Fibrinolysis After 16 Years: DANAMI-2

September 04, 2019

Another Step Forward for Genotype-Guided Prescribing After PCI: POPular Genetics

News Conference News ESC 2019

Another Step Forward for Genotype-Guided Prescribing After PCI: POPular Genetics

Yael L. Maxwell

September 03, 2019

Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT

News Conference News ESC 2019

Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT

Michael O'Riordan

September 03, 2019

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

News Conference News ESC 2019

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

September 03, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.